The one-of-a-kind CPI is a benchmark of retail sales pricing across cannabis products in select legalized U.S. markets. This month’s CPI has expanded to include reporting from Nevada.
Updated coverage in six Western states (AZ, CA, CO, NV, OR and WA) represent approximately 70 percent of legalized U.S. sales in 2018. Underlying pricing data is the compilation of actual dispensary transactions captured by BDS Analytics’ GreenEdge™ Retail Sales Tracking Platform. The baseline of measurement represents the launch of adult-use sales in California in January of 2018. In order to standardize retail pricing data for Flower and Concentrates, all transactions are converted to price per gram. For Ingestibles, Topicals and Vape, sales are normalized to a price per unit measure.
BDS Analytics’ CPI is unique in its ability to index retail pricing across all product categories, a significant insight considering the rapid market growth largely driven by branded products in all categories.
BDS Analytics’ CPI for June 2019 stands at 99.09, representing a two percent increase from the trailing month. Compared to June 2018, average retail prices have declined two percent. Year-to-date average retail prices have remained relatively constant.
The index score is positive for Pre-Rolled Joints, Ingestibles and Topicals, indicating an increase of the average retail price of these product categories relative to January 2018. Other product categories, such as Flower, Vape, and Dabbable Concentrates, have negative CPI scores. The average retail prices of both Flower and Topicals increased by nearly two and three points, respectively, when compared to the trailing month, whereas the average retail prices declined for Concentrates (comprising of Vape and Dabbable Concentrates), which is indicative of falling prices when compared to January 2018. The average retail prices of Ingestibles and Pre-Rolled Joints also increased slightly over the trailing month.
